Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125031 · ClinicalTrials.gov registry record · NA
Comparison of Noninvasive Hemoglobin Disposable Sensors
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03125031 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 44 participants.
The verdict
NCT03125031, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of two noninvasive hemoglobin sensors will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Interventions
- DEVICE Rainbow adhesive adult/pediatric sensor
- DEVICE Rainbow adhesive adult/neonatal sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-07-10 |
| Est. Completion | 2014-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125031
The ClinicalTrials.gov registry entry for NCT03125031 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rainbow adhesive adult/pediatric sensor is the first listed.
NCT03125031 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03125031 about?
NCT03125031 is a clinical study titled "Comparison of Noninvasive Hemoglobin Disposable Sensors". In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of two noninvasive hemoglobin sensors will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
What is the current status of trial NCT03125031?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2014-07-10. Estimated completion is 2014-07-25.
What interventions are being tested in trial NCT03125031?
The interventions under investigation include: Rainbow adhesive adult/pediatric sensor (DEVICE), Rainbow adhesive adult/neonatal sensor (DEVICE).
Who is sponsoring clinical trial NCT03125031?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.